Systems and methods for screening and managing insomnia

By analyzing sleep-wake signals and related parameters from users' physiological data, the system automatically identifies insomnia types, solving the problem of subjective reporting errors and enabling accurate insomnia diagnosis and personalized treatment, thereby improving sleep quality and treatment adherence.

CN117084631BActive Publication Date: 2026-11-17RESMED SENSOR TECH LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202310983015.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-10-31
Filing Date
2020-10-29
Publication Date
2026-11-17
Estimated Expiration
2040-10-29

AI Technical Summary

Technical Problem

Existing methods for screening and diagnosing insomnia rely on subjective reports, which are prone to errors and make it difficult to distinguish insomnia from other sleep-related disorders, resulting in poor treatment outcomes.

Method used

By receiving physiological data associated with the user, the system analyzes sleep-wake signals and sleep-related parameters using electronic interfaces and control systems, automatically identifies the type and severity of insomnia, and provides personalized treatment in conjunction with a respiratory therapy system.

Benefits of technology

It improves the accuracy of insomnia diagnosis, ensures appropriate treatment plans, reduces compliance issues with respiratory therapy systems, and enhances sleep quality and daytime function.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117084631B_ABST
    Figure CN117084631B_ABST
Patent Text Reader

Abstract

This invention discloses a system and method for screening and managing insomnia. The system includes: one or more sensors configured to generate first physiological data associated with a user during a first sleep period; a treatment system; a memory storing machine-readable instructions; and a control system including one or more processors configured to execute the machine-readable instructions to: determine, at least partially based on the physiological data, a user's sleep-wake signal during the first sleep period; determine, at least partially based on the sleep-wake signal, one or more sleep-related parameters of the user during the first sleep period; determine, at least partially based on the one or more sleep-related parameters, that the user experienced insomnia during the first sleep period; and, in response to determining that the user experienced insomnia during the first sleep period, identify the type of insomnia experienced by the user, at least partially based on the one or more sleep-related parameters.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Cross-references to related applications

[0002] This application claims the benefit and priority of U.S. Provisional Patent Application No. 62 / 928,508, filed October 31, 2019, the entire contents of which are incorporated herein by reference. Technical Field

[0003] This invention generally relates to systems and methods for screening and monitoring insomnia, and more specifically, to systems and methods for determining whether a user experiences insomnia during sleep periods. Background Technology

[0004] Many individuals suffer from insomnia (e.g., difficulty falling asleep, frequent or prolonged awakenings after initial sleep onset, and early awakenings that prevent them from returning to sleep) or other sleep-related conditions (e.g., periodic limb movement disorder (PLMD), obstructive sleep apnea (OSA), Cheyne-Stokes respiration (CSR), respiratory insufficiency, obesity-related hyperventilation syndrome (OHS), chronic obstructive pulmonary disease (COPD), neuromuscular disease (NMD), etc.). Many sleep-related conditions can be treated with respiratory systems (e.g., positive airway pressure (PAP) systems), while insomnia is treated differently (e.g., by improving sleep hygiene, using cognitive behavioral therapy, prescribing sleep medications, etc.). Therefore, it is advantageous to identify whether a user is experiencing insomnia or another sleep-related condition, directing the user to appropriate treatment. This invention aims to address these problems and resolve other needs. Summary of the Invention

[0005] According to some embodiments of the present invention, a method includes receiving physiological data associated with a user during a sleep period. The method further includes determining, at least in part, the user's sleep-wake signals during the sleep period based on the received physiological data. The method further includes determining, at least in part, one or more sleep-related parameters of the user during the sleep period based on the sleep-wake signals. The method further includes determining, at least in part, that the user experienced insomnia during the sleep period based on at least one of the one or more sleep-related parameters. The method further includes identifying the type of insomnia experienced by the user, at least in part, based on the one or more sleep-related parameters.

[0006] According to some embodiments of the present invention, a system includes an electronic interface, a memory, and a control system. The electronic interface is configured to receive physiological data associated with a user. The memory stores machine-readable instructions. The control system includes one or more processors configured to execute the machine-readable instructions to determine, at least in part, sleep-wake signals for the user during a sleep period based on the physiological data. The control system is also configured to determine, at least in part, one or more sleep-related parameters of the user during the sleep period based on the sleep-wake signals. The control system is further configured to determine, at least in part, that the user experienced insomnia during the sleep period based on the one or more sleep-related parameters. The control system is further configured to, in response to determining that the user experienced insomnia during the sleep period, identify the type of insomnia experienced by the user, at least in part, based on the one or more sleep-related parameters.

[0007] According to some implementations of the present invention, a system includes: a sensor configured to generate physiological data associated with a user during a sleep period; a memory storing machine-readable instructions; and a control system including one or more processors configured to execute the machine-readable instructions to: determine, at least in part, a sleep-wake signal of the user during the sleep period based on the physiological data; determine, at least in part, one or more sleep-related parameters of the user during the sleep period based on the sleep-wake signal; determine, at least in part, that the user experienced insomnia during the sleep period based on the one or more sleep-related parameters; and, in response to determining that the user experienced insomnia during the sleep period, identify the type of insomnia experienced by the user based at least in part on the one or more sleep-related parameters.

[0008] According to some implementations of the present invention, a system includes: a first sensor configured to generate (i) first physiological data associated with a user during a first sleep period and (ii) second physiological data associated with a user during a second sleep period; a second sensor configured to generate third physiological data associated with a user after the first sleep period and before the second sleep period; a memory storing machine-readable instructions; and a control system including one or more processors configured to execute the machine-readable instructions to: receive the first physiological data generated by the first sensor during the user's first sleep period; determine, at least in part, a first sleep-wake signal of the user associated with the first sleep period based on the first physiological data; determine, at least in part, a first sleep-related parameter of the user associated with the first sleep period based on the first sleep-wake signal; compare the first sleep-related parameter with a predetermined threshold to determine whether the user experiences insomnia during the first sleep period; receive the second physiological data generated by the second sensor after the user's first sleep period and before the user's second sleep period; and adjust the predetermined threshold to an adjusted threshold different from the predetermined threshold based at least in part on the second physiological data. During the user's second sleep period, the system receives third physiological data generated by a first sensor, determines a second sleep-wake signal of the user associated with the second sleep period based at least in part on the second physiological data, determines a second sleep-related parameter of the user associated with the second sleep period based at least in part on the second sleep-wake signal, and compares the second sleep-related parameter with the adjusted threshold to determine whether the user experiences insomnia during the second sleep period.

[0009] The above overview is not intended to represent every embodiment or aspect of the invention. Additional features and advantages of the invention will become apparent from the detailed description and accompanying drawings. Attached Figure Description

[0010] Figure 1 This is a functional block diagram of a system for identifying whether a user experiences insomnia during sleep, according to some implementations of the present invention.

[0011] Figure 2 This is according to some implementations of the present invention. Figure 1 A perspective of the system and users;

[0012] Figure 3 This is a flowchart of a method for determining whether a user experiences insomnia during sleep periods, according to some implementations of the present invention.

[0013] Figure 4 An exemplary hypnosis diagram associated with a user during sleep is shown, according to some implementations of the present invention;

[0014] Figure 5 This is according to some implementations of the present invention. Figure 4 An exemplary timeline of sleep periods; and

[0015] Figure 6 This is a flowchart of a method for determining whether a user experiences insomnia during multiple sleep periods, according to some implementations of the present invention.

[0016] While the present invention is susceptible to various modifications and substitutions, specific implementations and embodiments thereof have been illustrated by way of example in the accompanying drawings and will be described in detail herein. However, it should be understood that this is not intended to limit the invention to the specific forms disclosed, but rather, the invention is intended to cover all modifications, equivalents, and substitutions falling within the spirit and scope of the invention as defined by the appended claims. Detailed Implementation

[0017] Many individuals suffer from insomnia, which is typically characterized by dissatisfaction with the quality or duration of sleep (e.g., difficulty falling asleep, frequent or prolonged awakenings after initial sleep onset, and early awakenings that fail to restore sleep). It is estimated that over 2.6 billion people worldwide experience some form of insomnia, and over 750 million have been diagnosed with insomnia. In the United States, the total economic burden of insomnia is estimated at $107.5 billion annually, accounting for 13.6% of all days missed at work and 4.6% of injuries requiring medical attention. Recent research also indicates that insomnia is the second most prevalent mental disorder and a major risk factor for depression.

[0018] Nighttime insomnia symptoms typically include, for example, reduced sleep quality, reduced sleep duration, insomnia onset, insomnia maintenance, early awakening, mixed insomnia, and / or paradoxical insomnia. Insomnia onset is characterized by difficulty initiating sleep at bedtime. Insomnia maintenance is characterized by frequent and / or prolonged awakenings during the night after initial sleep onset. Early awakening is characterized by waking in the early morning (e.g., before a target or desired wake-up time) and being unable to return to sleep. Comorbid insomnia refers to a type of insomnia where insomnia symptoms are at least partially caused by symptoms or complications of another physical or mental illness (e.g., anxiety, depression, medical condition, and / or medication use). Mixed insomnia refers to a combination of attributes of other types of insomnia (e.g., a combination of symptoms related to sleep onset, sleep maintenance, and early awakening). Paradoxical insomnia refers to a discrepancy or inconsistency between the user's perceived sleep quality and the user's actual sleep quality.

[0019] Diurnal (e.g., daytime) insomnia symptoms include fatigue, decreased energy, impaired cognition (e.g., attention, concentration, and / or memory), difficulty functioning in academic or professional settings, and / or mood disorders. These symptoms can lead to psychological complications such as poor performance, shortened reaction time, increased risk of depression, and / or increased risk of anxiety disorders. Insomnia symptoms can also lead to physical complications such as poor immune system function, high blood pressure, increased risk of heart disease, increased risk of diabetes, weight gain, and / or obesity.

[0020] Comorbid Insomnia and Sleep Apnea (COMISA) refers to the type of insomnia experienced by a subject in conjunction with obstructive sleep apnea (OSA). OSA can be measured based on the apnea-hypopnea index (AHI) and / or oxygen desaturation level. The AHI is calculated by dividing the number of apnea and / or hypopnea events experienced by an AHI user during a sleep period by the total number of hours of sleep in that period. An event can be, for example, an apnea lasting at least 10 seconds. An AHI less than 5 is considered normal. An AHI greater than or equal to 5 but less than 15 is considered an indicator of mild OSA. An AHI greater than or equal to 15 but less than 30 is considered an indicator of moderate OSA. An AHI greater than or equal to 30 is considered an indicator of severe OSA. In children, an AHI greater than 1 is considered abnormal.

[0021] Insomnia can also be classified based on its duration. For example, if insomnia symptoms occur for less than 3 months, they are considered acute or transient. Conversely, if insomnia symptoms occur for, for example, 3 months or longer, they are considered chronic or persistent. Persistent / chronic insomnia symptoms usually require a different treatment approach than acute / transient insomnia symptoms.

[0022] Known risk factors for insomnia include sex (e.g., insomnia is more common in women than in men), family history, and stress exposure (e.g., severe and chronic life events). Age is a potential risk factor for insomnia. For example, insomnia onset is more common in younger adults, while sleep maintenance insomnia is more common in middle-aged and older adults. Other potential risk factors for insomnia include race, geography (e.g., living in a geographic region with long winters), altitude, and / or other sociodemographic factors (e.g., socioeconomic status, employment, education level, self-reported health, etc.).

[0023] The mechanisms of insomnia include precipitating factors, triggering factors, and persistent factors. Precipitating factors include excessive arousal, characterized by increased physiological arousal during sleep and wakefulness. Measures of excessive arousal include, for example, increased cortisol levels, increased activity of the autonomic nervous system (e.g., as indicated by increased resting heart rate and / or changes in heart rate), increased brain activity (e.g., increased EEG frequency during sleep and / or increased number of awakenings during REM sleep), increased metabolic rate, increased body temperature, and / or increased activity of the pituitary-adrenal axis. Influencing factors include stressful life events (e.g., those related to employment or education, relationships, etc.). Influencing factors include excessive worry about sleep loss and its consequences, which can persist insomnia symptoms even after the influencing factors are removed.

[0024] Diagnosing or screening for insomnia (including identifying the type of insomnia and / or specific symptoms) typically involves a series of steps. The screening process usually begins with a subjective complaint from the patient (e.g., their inability to fall or stay asleep).

[0025] Next, clinicians use a checklist that includes insomnia symptoms, factors influencing those symptoms, health factors, and social factors to assess subjective complaints. Insomnia symptoms may include, for example, age of onset, onset event, time of onset, current symptoms (e.g., falling asleep, sleep maintenance, early awakening), symptom frequency (e.g., every night, episodic, specific night, specific situation, or seasonal variation), the course of symptoms since onset (e.g., severity and / or relative changes in symptoms), and / or perceived daytime consequences. Factors influencing insomnia symptoms include, for example, past and current treatments (including their effectiveness), factors that improve or alleviate symptoms, factors that exacerbate insomnia (e.g., stress or changes in schedule), and factors that maintain insomnia, including behavioral factors (e.g., going to bed too early, getting extra sleep on weekends, alcohol consumption, etc.) and cognitive factors (e.g., unhelpful beliefs about sleep, worries about the consequences of insomnia, fear of poor sleep, etc.). Health factors include medical conditions and symptoms, conditions that interfere with sleep (e.g., pain, discomfort, treatment), and pharmacological considerations (e.g., warnings and sedative effects of medications). Social factors include work schedules that are incompatible with sleep, late nights with no time to relax, evening family and social responsibilities (e.g., caring for children or the elderly), stressful life events (e.g., past stressful events may be triggers and current stressful events may be permanent), and / or sleeping with pets.

[0026] After clinicians complete checklists and assess insomnia symptoms, influencing factors, health factors, and / or social factors, patients are typically guided to create a daily sleep diary and / or complete questionnaires (e.g., the Insomnia Severity Index or the Pittsburgh Sleep Quality Index). Therefore, this routine approach to insomnia screening and diagnosis is susceptible to error because it relies on subjective complaints rather than objective sleep assessments. Due to sleep state illusions (paradoxical insomnia), a disconnect may exist between a patient's subjective complaints and actual sleep.

[0027] Furthermore, traditional diagnostic methods for insomnia do not exclude other sleep-related disorders, such as periodic limb movement disorder (PLMD), restless legs syndrome (RLS), sleep-disordered breathing (SDB), obstructive sleep apnea (OSA), Cheyne-Stokes respiration (CSR), respiratory insufficiency, obesity-related hyperventilation syndrome (OHS), chronic obstructive pulmonary disease (COPD), neuromuscular diseases (NMD), and chest wall disorders. These other disorders are characterized by specific events that occur during an individual's sleep (e.g., snoring, apnea, hypopnea, restless legs, sleep disturbances, apnea, increased heart rate, dyspnea, asthma attacks, seizures, epilepsy, or any combination thereof). While these other sleep-related disorders can have symptoms similar to insomnia, differentiating them from insomnia can be used to tailor effective treatment plans that may require different treatments. For example, fatigue is often characteristic of insomnia, while excessive daytime sleepiness is a characteristic feature of other disorders (e.g., PLMD) and reflects a physiological tendency to fall asleep involuntarily.

[0028] Once diagnosed, insomnia can be managed or treated using a variety of techniques or by providing advice to the patient. Generally, patients can be encouraged or advised to develop healthy sleep habits (e.g., plenty of exercise and daytime activity, a regular lifestyle, avoiding daytime naps, eating dinner early, relaxing before bed, avoiding caffeine in the afternoon, avoiding alcohol, making the bedroom comfortable, eliminating bedroom distractions, waking up when not sleepy, and trying to wake up at the same time every day, regardless of bedtime) or certain habits can be discouraged (e.g., not working in bed, not going to bed early, not going to bed unless tired). Sleep medications and medical therapies, such as prescription sleep aids, over-the-counter sleep aids, and / or home herbal remedies, can be used additionally or optionally to treat the patient.

[0029] Cognitive behavioral therapy (CBT) or cognitive behavioral therapy for insomnia (CBT-I) can also be used to treat patients, which typically includes sleep hygiene education, relaxation therapy, stimulus control, sleep restriction, and sleep management tools and devices. Sleep restriction is a method designed to limit time spent in bed (sleep window or duration) to actual sleep, enhancing homeostatic sleep drives. The sleep window can be gradually increased over a period of days or weeks until the patient reaches their optimal sleep duration. Stimulus control involves providing the patient with a set of instructions designed to strengthen the association between the bed and bedroom and sleep, and to re-establish a consistent sleep-wake schedule (e.g., going to bed only when sleepy, getting out of bed when unable to sleep, using the bed only for sleep (e.g., not reading or watching TV), waking up at the same time every morning, and not napping). Relaxation training includes clinical procedures designed to reduce voluntary arousal, muscle tension, and intrusive thoughts that interfere with sleep (e.g., using progressive muscle relaxants). Cognitive therapy is a psychological approach designed to reduce excessive worry about sleep and reconstruct unhelpful beliefs about insomnia and its daytime consequences (e.g., using Socratic questions, behavioral experiences, and paradoxical intentions techniques). Sleep hygiene education includes general guidelines on health practices that may interfere with sleep (e.g., diet, exercise, substance use) and environmental factors (e.g., light, noise, excessively high temperatures). Mind-based interventions may include, for example, meditation.

[0030] Reference Figure 1 The present invention describes a system 100 according to some implementations thereof. System 100 includes a control system 110, a memory device 114, an electronic interface 119, a respiratory therapy system 120, one or more microphones 130, and one or more user devices 170.

[0031] The control system 110 includes one or more processors 112 (hereinafter, processor 112). The control system 110 is typically used to control (e.g., actuate) various components of the system 100 and / or analyze data acquired and / or generated by the components of the system 100. The processor 112 may be a general-purpose or special-purpose processor or a microprocessor. Although in Figure 1A processor 112 is shown, but the control system 110 may include any suitable number of processors (e.g., one processor, two processors, five processors, ten processors, etc.), which may be located in a single housing or positioned remotely from each other. The control system 110 may be coupled to and / or located within, for example, the housing of user equipment 170, a portion of respiratory system 120 (e.g., a housing), and / or the housing of one or more sensors 130. The control system 110 may be centralized (within one such housing) or distributed (within two or more physically different such housings). In this embodiment, which includes two or more housings containing the control system 110, such housings may be positioned close to and / or far from each other.

[0032] Memory device 114 stores machine-readable instructions executable by processor 112 of control system 110. Memory device 114 can be any suitable computer-readable storage device or medium, such as random or serial access storage devices, hard disk drives, solid-state drives, flash memory devices, etc. Although Figure 1 A memory device 114 is shown, but system 100 may include any suitable number of memory devices 114 (e.g., one memory device, two memory devices, five memory devices, ten memory devices, etc.). The memory device 114 may be coupled to and / or located within the housing of the breathing device 122, the housing of the external device 170, the housing of one or more sensors 130, or any combination thereof. Similar to control system 110, the memory device 114 may be centralized (within one such housing) or distributed (within two or more physically different such housings).

[0033] In some implementations, memory device 114 ( Figure 1The system stores user profiles associated with each user. User profiles may include, for example, user-associated demographic information, user-associated biostatistics, user-associated medical information, self-reported user feedback, user-associated sleep parameters (e.g., sleep-related parameters recorded from one or more earlier sleep periods), or any combination thereof. Demographic information may include, for example, information indicating the user's age, gender, ethnicity, geographic location, relationship status, family history of insomnia, employment status, education level, socioeconomic status, or any combination thereof. Medical information may include, for example, information indicating one or more medical conditions associated with the user, medication use, or both. Medical information data may further include Multisleep Waiting Time Test (MSLT) results or scores and / or Pittsburgh Sleep Quality Index (PSQI) scores or values. Self-reported user feedback may include information indicating self-reported subjective sleep scores (e.g., poor, average, excellent), user's self-reported subjective stress levels, user's self-reported subjective fatigue levels, user's self-reported subjective health status, recent life events experienced by the user, or any combination thereof.

[0034] Electronic interface 119 is configured to receive data (e.g., physiological data and / or audio data) from one or more sensors 130, such that the data can be stored in memory device 114 and / or analyzed by processor 112 of control system 110. Electronic interface 119 can communicate with one or more sensors 130 using wired or wireless connections (e.g., using RF communication protocols, WiFi communication protocols, Bluetooth communication protocols, via cellular networks, etc.). Electronic interface 119 may include an antenna, a receiver (e.g., an RF receiver), a transmitter (e.g., an RF transmitter), a transceiver, or any combination thereof. Electronic interface 119 may also include one or more processors and / or one or more memory devices that are the same as or similar to processor 112 and memory device 114 described herein. In some implementations, electronic interface 119 is coupled to or integrated into user equipment 170. In other implementations, electronic interface 119 is coupled to or integrated with control system 110 and / or memory device 114 (e.g., within a housing).

[0035] In some implementations, system 100 may optionally include a respiratory system 120 (also referred to as a respiratory therapy system). The respiratory system 120 may include a respiratory pressure therapy device 122 (referred to as respiratory device 122), a user interface 124, a conduit 126 (also referred to as a tube or air circuit), a display device 128, a humidifier canister 129, or any combination thereof. In some implementations, a control system 110, a memory device 114, a display device 128, one or more sensors 130, and a humidifier canister 129 are part of the respiratory device 122. Respiratory pressure therapy refers to supplying air to the user's airway inlet at a controlled target pressure that is nominally positive relative to atmosphere throughout the user's respiratory cycle (e.g., the opposite of negative pressure therapy with a canister ventilator or tubing ventilator). The respiratory system 120 is typically used to treat individuals suffering from one or more sleep-related breathing disorders (e.g., obstructive sleep apnea, central sleep apnea, or mixed sleep apnea).

[0036] Breathing device 122 is typically used to generate pressurized air to be delivered to a user (e.g., using one or more motors driving one or more compressors). In some implementations, breathing device 122 generates a continuous, constant air pressure that is delivered to the user. In other implementations, breathing device 122 generates two or more predetermined pressures (e.g., a first predetermined air pressure and a second predetermined air pressure). In still other implementations, breathing device 122 is configured to generate a variety of different air pressures within a predetermined range. For example, breathing device 122 may deliver at least about 6 cm H2O, at least about 10 cm H2O, at least about 20 cm H2O, between about 6 cm H2O and about 10 cm H2O, between about 7 cm H2O and about 12 cm H2O, etc. Breathing device 122 may also deliver pressurized air at predetermined flow rates, for example, between about -20 L / min and about 150 L / min, while maintaining positive pressure (relative to ambient pressure).

[0037] User interface 124 engages with a portion of the user's face and delivers pressurized air from breathing device 122 to the user's airway to help prevent airway narrowing and / or collapse during sleep. This can also increase the user's oxygen intake during sleep. Depending on the treatment to be applied, user interface 124 may form a seal with, for example, an area or portion of the user's face, thereby facilitating the delivery of gas at a pressure sufficiently different from ambient pressure (e.g., a positive pressure of approximately 10 cm H2O relative to ambient pressure) to achieve the treatment. For other forms of treatment, such as oxygen delivery, the user interface may not include a seal sufficient to facilitate the delivery of a gas supply at a positive pressure of approximately 10 cm H2O to the airway.

[0038] like Figure 2 As shown, in some implementations, user interface 124 is a mask covering the user's nose and mouth. Alternatively, user interface 124 may be a nasal mask that delivers air to the user's nose or a nasal pillow mask that delivers air directly to the user's nostrils. User interface 124 may include multiple straps (e.g., including hook and loop fasteners) for positioning and / or stabilizing the interface on a part of the user (e.g., face) and conformal cushioning pads (e.g., silicone, plastic, foam, etc.) to help provide an airtight seal between user interface 124 and the user. In some examples, user interface 124 may be a tubular mask, wherein the straps of the mask are configured to serve as one or more conduits for delivering pressurized air to the mask or nasal mask. User interface 124 may also include one or more vents for allowing carbon dioxide and other gases exhaled by user 210 to escape. In other implementations, user interface 124 may include a mouthpiece (e.g., a night-protective mouthpiece molded to conform to the user's teeth, a jaw repositioning device, etc.).

[0039] The conduit 126 (also referred to as an air circuit or tube) allows air to flow between two components of the respiratory system 120, such as the breathing device 122 and the user interface 124. In some implementations, there may be separate branches for the inspiratory and expiratory conduits. In other implementations, a single-branch air conduit is used for both inspiratory and expiratory breathing.

[0040] One or more of the breathing device 122, user interface 124, tubing 126, display device 128, and humidifier 129 may include one or more sensors (e.g., pressure sensor, flow sensor, or any other sensor 130 described more generally herein). These one or more sensors may be used, for example, to measure the air pressure and / or flow rate of the pressurized air supplied by the breathing device 122.

[0041] Display device 128 is typically used to display images, including still images, video images, or both, and / or information about respiratory device 122. For example, display device 128 may provide information about the status of respiratory device 122 (e.g., whether respiratory device 122 is on / off, the pressure of the air delivered by respiratory device 122, the temperature of the air delivered by respiratory device 122, etc.) and / or other information (e.g., sleep scores or treatment scores (such as myAir™ scores), current date / time, personal information of user 210, etc.). In some implementations, display device 128 acts as a human-machine interface (HMI) including a graphical user interface (GUI) configured to display images as an input interface. Display device 128 may be an LED display, OLED display, LCD display, etc. The input interface may be, for example, a touchscreen or touch-sensitive substrate, a mouse, a keyboard, or any sensor system configured to sense input made by a human user interacting with respiratory device 122.

[0042] The humidifier canister 129 is connected to or integrated into the breathing apparatus 122 and includes a water reservoir for humidifying pressurized air delivered from the breathing apparatus 122. The breathing apparatus 122 may include a heater to heat the water in the humidifier canister 129 to humidify the pressurized air supplied to the user. Additionally, in some implementations, the conduit 126 may include a heating element (e.g., coupled to and / or embedded in the conduit 126) that heats the pressurized air delivered to the user.

[0043] The respiratory system 120 can be used as, for example, a ventilator or a positive airway pressure (PAP) system, such as a continuous positive airway pressure (CPAP) system, an automated positive airway pressure (APAP) system, a bilevel or variable positive airway pressure (BPAP or VPAP) system, or any combination thereof. A CPAP system delivers a predetermined pressure (e.g., determined by a sleep physician) to the user. An APAP system automatically changes the pressure delivered to the user based on, for example, breathing data relevant to the user. A BPAP or VPAP system is configured to deliver a first predetermined pressure (e.g., inspiratory positive airway pressure or IPAP) and a second predetermined pressure lower than the first predetermined pressure (e.g., expiratory positive airway pressure or EPAP).

[0044] Reference Figure 2 The system 100 is shown according to some implementation methods. Figure 1Part of the breathing system 120. The user 210 and bed partner 220 are located in the bed 230 and lying on the mattress 232. A user interface 124 (e.g., a full-face mask) can be worn by the user 210 during sleep. The user interface 124 is fluidly coupled and / or connected to the breathing device 122 via a conduit 126. The breathing device 122, in turn, delivers pressurized air to the user 210 via the conduit 126 and the user interface 124 to increase the air pressure in the user 210's throat, thereby helping to prevent airway closure and / or narrowing during sleep. The breathing device 122 may be positioned such as... Figure 2 The bedside table 240 shown is directly adjacent to the bed 230, or more generally, is positioned on any surface or structure that is typically adjacent to the bed 230 and / or the user 210.

[0045] Generally, compared to not using the breathing system 120 (especially when the user suffers from sleep apnea or other sleep-related conditions), users designated to use the breathing system 120 tend to experience higher quality sleep and less fatigue throughout the day following use. However, many users do not adhere to their prescribed usage because the user interface 124 is uncomfortable or cumbersome, or due to other side effects (e.g., dry eyes, dry throat, noise, etc.). Users are more likely to fail to use the breathing system 120 as prescribed (or discontinue use altogether) if they do not perceive any benefit they are experiencing (e.g., reduced daytime fatigue). However, a lack of improvement in sleep quality or daytime fatigue may be due to insomnia rather than a lack of therapeutic efficacy. Therefore, it is beneficial to identify whether a user of the breathing therapy system is experiencing insomnia so that insomnia symptoms can be treated appropriately, and users will not discontinue or reduce their use of the breathing therapy system due to perceived lack of benefit (e.g., caused by insomnia attacks).

[0046] While the respiratory therapy system 120 described herein is an example of a treatment system, other types of treatment systems for adjunctive treatment of sleep-related conditions are conceivable. Other treatment systems may include oral appliances, such as dental appliances or mandibular repositioning devices (MRDs). Oral appliance therapy helps prevent collapse of the soft tissues at the back of the tongue and throat by supporting the jaw (mandible) in an forward position, keeping the user's airway open during sleep.

[0047] See again Figure 1The system 100 includes one or more sensors 130, such as a pressure sensor 132, a flow sensor 134, a temperature sensor 136, a motion sensor 138, a microphone 140, a speaker 142, a radio frequency (RF) receiver 146, an RF transmitter 148, a camera 150, an infrared sensor 152, a photoplethysmography (PPG) sensor 154, an electrocardiogram (ECG) sensor 156, an EEG sensor 158, a capacitance sensor 160, a force sensor 162, a strain gauge sensor 164, an electromyography (EMG) sensor 166, an oxygen sensor 168, an analyte sensor 174, a humidity sensor 176, a lidar sensor 178, or any combination thereof. Typically, each of the one or more sensors 130 is configured to output sensor data that is received and stored in a memory device 114 or one or more other memory devices.

[0048] Although one or more sensors 130 are shown and described as including each of the following: pressure sensor 132, flow sensor 134, temperature sensor 136, motion sensor 138, microphone 140, speaker 142, RF receiver 146, RF transmitter 148, camera 150, infrared sensor 152, photoplethysmography (PPG) sensor 154, electrocardiogram (ECG) sensor 156, EEG sensor 158, capacitance sensor 160, force sensor 162, strain gauge sensor 164, electromyography (EMG) sensor 166, oxygen sensor 168, analyte sensor 174, humidity sensor 176, and lidar sensor 178, more generally, one or more sensors 130 may include any combination and any number of each of the sensors described and / or shown herein.

[0049] One or more sensors 130 can be used to generate, for example, physiological data, audio data, or both. The control system 110 can use the physiological data generated by the one or more sensors 130 to determine sleep-wake signals and one or more sleep-related parameters associated with the user during a sleep period. Sleep-wake signals can indicate one or more sleep states, including wakefulness, relaxed wakefulness, micro-wakefulness, rapid eye movement (REM) stage, first non-REM stage (commonly referred to as "N1"), second non-REM stage (commonly referred to as "N2"), third non-REM stage (commonly referred to as "N3"), or any combination thereof. Sleep-wake signals can also be timestamped to indicate the time the user entered bed, the time the user left bed, the time the user attempted to fall asleep, etc. Sleep-wake signals can be measured by the sensors 130 during a sleep period at a predetermined sampling rate, such as one sample per second, one sample per 30 seconds, or one sample per minute. Examples of one or more sleep-related parameters that can be determined for a user based on sleep-wake signals during a sleep period include total bedtime, total sleep time, sleep onset wait time, sleep-wake parameters, sleep efficiency, segmentation index, or any combination thereof.

[0050] The sleep-wake signal can also be timestamped to indicate the time the user entered bed, the time the user left bed, the time the user attempted to fall asleep, etc. The sleep-wake signal of sensor 130 can be measured during the sleep period at a predetermined sampling rate (e.g., one sample per second, one sample every 30 seconds, one sample per minute, etc.). In some implementations, the sleep-wake signal can also indicate respiratory signals, respiratory rate, inspiratory amplitude, expiratory amplitude, inspiratory-expiratory ratio, number of events per hour, event pattern, pressure setting of breathing device 122, or any combination thereof, during the sleep period. Events can include snoring, sleep apnea, central sleep apnea, obstructive sleep apnea, mixed sleep apnea, hypopnea, mask leakage (e.g., from user interface 124), restless legs, sleep disturbance, choking, increased heart rate, difficulty breathing, asthma attack, seizure, epilepsy, or any combination thereof. One or more sleep-related parameters that can be determined for a user during sleep periods based on sleep-wake signals include, for example, total time in bed, total sleep time, sleep onset wait time, sleep-wake parameters, sleep efficiency, segmentation index, or any combination thereof. As described further in detail herein, these sleep-related parameters can be analyzed to determine whether the user experiences insomnia during sleep, identify the type of insomnia, and / or identify insomnia symptoms.

[0051] Physiological and / or audio data generated by one or more sensors 130 can also be used to determine respiratory signals associated with the user during sleep periods. Respiratory signals typically represent the user's breathing during sleep periods. Respiratory signals can indicate, for example, respiratory rate, respiratory rate variability, inspiratory amplitude, expiratory amplitude, inspiratory-expiratory ratio, number of events per hour, event pattern, pressure setting of breathing device 122, or any combination thereof. Events may include snoring, sleep apnea, central sleep apnea, obstructive sleep apnea, mixed sleep apnea, hypopnea, mask leakage (e.g., from user interface 124), restless legs, sleep disturbance, choking, increased heart rate, difficulty breathing, asthma attack, seizure, epilepsy, or any combination thereof.

[0052] Pressure sensor 132 outputs pressure data that can be stored in memory device 114 and / or analyzed by processor 112 of control system 110. In some implementations, pressure sensor 132 is an air pressure sensor (e.g., an atmospheric pressure sensor) that generates sensor data indicating the breathing (e.g., inhalation and / or exhalation) and / or ambient pressure of the user of respiratory system 120. In such implementations, pressure sensor 132 can be coupled to or integrated into respiratory device 122. Pressure sensor 132 can be, for example, a capacitive sensor, an electromagnetic sensor, a piezoelectric sensor, a strain gauge sensor, an optical sensor, a potentiometric sensor, or any combination thereof. In one example, pressure sensor 132 can be used to determine the user's blood pressure.

[0053] The flow sensor 134 outputs flow data that can be stored in the memory device 114 and / or analyzed by the processor 112 of the control system 110. In some implementations, the flow sensor 134 is used to determine the airflow rate from the breathing device 122, the airflow rate through the duct 126, the airflow rate through the user interface 124, or any combination thereof. In this implementation, the flow sensor 134 can be coupled to or integrated into the breathing device 122, the user interface 124, or the duct 126. The flow sensor 134 can be a mass flow sensor, such as a rotary flow meter (e.g., a Hall effect flow meter), a turbine flow meter, an orifice flow meter, an ultrasonic flow meter, a hot-wire sensor, an eddy current sensor, a membrane sensor, or any combination thereof.

[0054] Temperature sensor 136 outputs temperature data that can be stored in memory device 114 and / or analyzed by processor 112 of control system 110. In some implementations, temperature sensor 136 generates instructions for user 210 ( Figure 2Temperature data may include core body temperature, user 210 skin temperature, temperature of air flowing from breathing device 122 and / or through conduit 126, temperature in user interface 124, ambient temperature, or any combination thereof. Temperature sensor 136 may be, for example, a thermocouple sensor, a thermistor sensor, a silicon bandgap temperature sensor or a semiconductor-based sensor, a resistance temperature detector, or any combination thereof.

[0055] The microphone 140 output can be stored in memory device 114 and / or analyzed by processor 112 of control system 110. The audio data generated by microphone 140 can be reproduced as one or more sounds (e.g., a sound from user 210) during sleep periods. The audio data from microphone 140 can also be used to identify (e.g., using control system 110) events experienced by the user during sleep periods, as described further in detail herein. Microphone 140 can be coupled to or integrated into breathing device 122, interface 124, catheter 126, or user device 170.

[0056] The speaker 142 outputs to the user of the system 100 (e.g., Figure 2 The speaker 142 can be used as, for example, an alarm clock or to play alarms or messages to the user 210 (e.g., in response to an event). In some implementations, the speaker 142 can be used to transmit audio data generated by the microphone 140 to the user. The speaker 142 can be coupled to or integrated into the breathing device 122, user interface 124, catheter 126, or user equipment 170.

[0057] Microphone 140 and speaker 142 can be used as separate devices. In some implementations, microphone 140 and speaker 142 can be combined into acoustic sensor 141, as described, for example, in WO2018 / 050913, which is incorporated herein by reference in its entirety. In this implementation, speaker 142 generates or emits sound waves at predetermined intervals, and microphone 140 detects reflections of emitted sound waves from speaker 142. The sound waves generated or emitted by speaker 142 have frequencies inaudible to the human ear (e.g., below 20 Hz or above about 18 kHz) so as not to disturb the sleep of user 210 or bed partner 220. Figure 2 Based at least in part on data from microphone 140 and / or speaker 142, control system 110 can determine user 210 ( Figure 2 The location of the sleep and / or one or more sleep-related parameters described herein.

[0058] In some embodiments, sensor 130 includes (i) a first microphone that is the same as or similar to microphone 140 and is integrated in acoustic sensor 141; and (ii) a second microphone that is the same as or similar to microphone 140, but is separate from and different from the first microphone integrated in acoustic sensor 141.

[0059] RF transmitter 148 generates and / or transmits radio waves with a predetermined frequency and / or predetermined amplitude (e.g., in the high-frequency band, in the low-frequency band, long-wave signal, short-wave signal, etc.). RF receiver 146 detects the reflection of the radio waves emitted from RF transmitter 148, and this data can be analyzed by control system 110 to determine the user 210 (…). Figure 2 The location of the device and / or one or more of the sleep-related parameters described herein. An RF receiver (RF receiver 146 and RF transmitter 148 or another RF pair) may also be used for wireless communication between the control system 110, the breathing device 122, one or more sensors 130, the user equipment 170, or any combination thereof. While RF receiver 146 and RF transmitter 148 are in... Figure 1 While shown as separate and distinct components, in some implementations, the RF receiver 146 and the RF transmitter 148 are combined as part of the RF sensor 147. In some such implementations, the RF sensor 147 includes control circuitry. The specific format for RF communication may be WiFi, Bluetooth, etc.

[0060] In some implementations, the RF sensor 147 is part of a mesh system. An example of a mesh system is a WiFi mesh system, which may include mesh nodes, mesh routers, and mesh gateways, each of which may be mobile / movable or fixed. In such an implementation, the WiFi mesh system includes WiFi routers and / or WiFi controllers and one or more satellites (e.g., access points), each satellite including the same or similar RF sensor as the RF sensor 147. The WiFi routers and satellites communicate continuously with each other using WiFi signals. The WiFi mesh system can be used to generate motion data based on variations in the WiFi signals between the routers and satellites (e.g., differences in received signal strength), said variations being caused by a moving object or person partially blocking the signal. The motion data may indicate movement, breathing, heart rate, gait, falls, behavior, etc., or any combination thereof.

[0061] Camera 150 outputs image data that can be reproduced as one or more images (e.g., still images, video images, thermal images, or combinations thereof) that can be stored in memory device 114. Image data from camera 150 can be used by control system 110 to determine one or more of the sleep-related parameters described herein. For example, image data from camera 150 can be used to identify the user's location and determine when user 210 is in bed 230. Figure 2 The time of departure of user 210 from bed 230, and the time of departure of user 210 from bed 230.

[0062] Infrared (IR) sensor 152 outputs infrared image data that can be reproduced as one or more infrared images (e.g., still images, video images, or both) that can be stored in memory device 114. The infrared data from IR sensor 152 can be used to determine one or more sleep-related parameters during a sleep period, including the user 210's temperature and / or the user 210's movement. IR sensor 152 can also be used in conjunction with camera 150 when measuring the presence, location, and / or movement of user 210. For example, IR sensor 152 can detect infrared light with wavelengths between about 700 nm and about 1 mm, while camera 150 can detect visible light with wavelengths between about 380 nm and about 740 nm.

[0063] PPG sensor 154 output and user 210 ( Figure 2 The associated physiological data can be used to determine one or more sleep-related parameters, such as heart rate, heart rate variability, cardiac cycle, respiratory rate, inspiratory amplitude, expiratory amplitude, inspiratory-expiratory ratio, estimated blood pressure parameters, or any combination thereof. The PPG sensor 154 can be worn by the user 210, embedded in clothing and / or fabric worn by the user 210, embedded in and / or connected to the user interface 124 and / or its associated helmet (e.g., straps, etc.).

[0064] ECG sensor 156 outputs physiological data associated with the electrical activity of the heart of user 210. In some implementations, ECG sensor 156 includes one or more electrodes located above or around a portion of user 210 during sleep periods. Physiological data from ECG sensor 156 can be used, for example, to determine one or more of the sleep-related parameters described herein.

[0065] EEG sensor 158 outputs physiological data associated with the electrical activity of the user 210's brain. In some embodiments, EEG sensor 158 includes one or more electrodes positioned on or around the user 210's scalp during sleep. Physiological data from EEG sensor 158 can be used, for example, to determine the user 210's sleep state at any given time during a sleep period. In some implementations, EEG sensor 158 may be integrated into user interface 124 and / or an associated helmet (e.g., a strap, etc.).

[0066] The capacitive sensor 160, force sensor 162, and strain gauge sensor 164 output data that can be stored in memory device 114 and used by control system 110 to determine one or more of the sleep-related parameters described herein. EMG sensor 166 outputs physiological data related to electrical activity generated by one or more muscles. Oxygen sensor 168 outputs oxygen data indicating the oxygen concentration of a gas (e.g., in conduit 126 or at user interface 124). Oxygen sensor 168 can be, for example, an ultrasonic oxygen sensor, an electro-oxygen sensor, a chemical oxygen sensor, an optical oxygen sensor, or any combination thereof. In some embodiments, one or more sensors 130 further include a ground-skin response (GSR) sensor, a blood flow sensor, a respiration sensor, a pulse sensor, a blood pressure sensor, a blood oxygen sensor, or any combination thereof.

[0067] Analyte sensor 174 can be used to detect the presence of analytes in the exhaled breath of user 210. Data output from analyte sensor 174 can be stored in memory device 114 and used by control system 110 to determine the identity and concentration of any analytes in the breath of user 210. In some implementations, analyte sensor 174 is located near the mouth of user 210 to detect analytes in the breath exhaled from the mouth of user 210. For example, when user interface 124 is a mask covering the nose and mouth of user 210, analyte sensor 174 can be located inside the mask to monitor mouth breathing of user 210. In other implementations, such as when user interface 124 is a nasal mask or nasal pillow mask, analyte sensor 174 can be positioned near the nose of user 210 to detect analytes in the breath exhaled through the nose of user 210. In other implementations, when user interface 124 is a nasal mask or nasal pillow mask, analyte sensor 174 can be located near the mouth of user 210. In this implementation, the analyte sensor 174 can be used to detect whether any air is unintentionally leaking from the mouth of user 210. In some implementations, the analyte sensor 174 is a volatile organic compound (VOC) sensor that can be used to detect carbon-based chemicals or compounds. In some embodiments, the analyte sensor 174 can also be used to detect whether user 210 is breathing through their nose or mouth. For example, if the presence of an analyte is detected by data output from the analyte sensor 174 located near the mouth of user 210 or inside a mask (in the implementation where user interface 124 is a mask), the control system 110 can use that data as an indication that user 210 is breathing through their mouth.

[0068] The humidity sensor 176 outputs data that can be stored in the storage device 114 and used by the control system 110. The humidity sensor 176 can be used to detect humidity in various areas surrounding the user (e.g., inside the conduit 126 or user interface 124, near the user 210's face, near the connection between the conduit 126 and user interface 124, near the connection between the conduit 126 and breathing device 122, etc.). Therefore, in some implementations, the humidity sensor 176 can be coupled to or integrated into the user interface 124 or the conduit 126 to monitor the humidity of pressurized air from the breathing device 122. In other implementations, the humidity sensor 176 is placed near any area where the humidity level needs to be monitored. The humidity sensor 176 can also be used to monitor the humidity of the surrounding environment around the user 210, such as the air in a bedroom.

[0069] The optical detection and ranging (LiDAR) sensor 178 can be used for depth sensing. This type of optical sensor (e.g., a laser sensor) can be used to detect objects and construct a three-dimensional (3D) map of the surrounding environment (e.g., a living space). LiDAR typically utilizes pulsed lasers for time-of-flight measurements. LiDAR is also known as 3D laser scanning. In an example using this sensor, a fixed or mobile device (such as a smartphone) with LiDAR sensor 166 can measure and map an area extending 5 meters or more from the sensor. For example, LiDAR data can be fused with point cloud data estimated by an electromagnetic RADAR sensor. LiDAR sensor 178 can also use artificial intelligence (AI) to automatically geofence the RADAR system by detecting and classifying features in the space that may cause problems for the RADAR system, such as glass windows (which may be highly reflective to RADAR). For example, LiDAR can also be used to provide an estimate of a person's height, and how that height changes when the person sits down or falls. LiDAR can be used to form a 3D mesh representation of the environment. In further applications, lidar can reflect radio waves off solid surfaces (e.g., transmissive materials) to allow for the classification of different types of obstacles.

[0070] In some implementations, system 100 also includes an activity tracker 180. The activity tracker 180 is typically used to help generate physiological data for determining activity measurements associated with a user. Activity measurements may include, for example, steps, distance traveled, steps climbed, duration of physical activity, type of physical activity, intensity of physical activity, time spent standing, respiratory rate, average respiratory rate, resting respiratory rate, maximum respiratory rate, respiratory rate variability, heart rate, average heart rate, resting heart rate, maximum heart rate, heart rate variability, calories burned, blood oxygen saturation, electrical skin activity (also known as skin conductance or skin response), or any combination thereof. The activity tracker 180 includes one or more sensors 130 described herein, such as motion sensors 138 (e.g., one or more accelerometers and / or gyroscopes), PPG sensors 154, and / or ECG sensors 156.

[0071] In some implementations, the activity tracker 180 is a wearable device that can be worn by the user, such as a smartwatch, wristband, ring, or patch. For example, see reference... Figure 2The activity tracker 190 is worn on the wrist of user 210. The activity tracker 190 can also be attached to or integrated into clothing or garments worn by the user. Alternatively, the activity tracker 190 can also be attached to or integrated into user equipment 170 (e.g., within the same housing). More generally, the activity tracker 190 can be communicatively attached to control system 110, memory 114, respiratory system 120, and / or user equipment 170, or physically integrated into the control system, memory device, respiratory system, and / or user equipment device (e.g., within a housing).

[0072] Although Figure 1 While shown separately, any combination of one or more sensors 130 may be integrated into and / or coupled to any one or more components of system 100, including breathing device 122, user interface 124, tubing 126, humidifier 129, control system 110, user device 170, or any combination thereof. For example, microphone 140 and speaker 142 may be integrated into and / or coupled to external device 170, and pressure sensor 130 and / or flow sensor 132 may be integrated into and / or coupled to breathing device 122. In some implementations, at least one of the one or more sensors 130 may not be coupled to breathing device 122, control system 110, or user device 170, and may be typically positioned near or in contact with user 210 during sleep periods (e.g., positioned on or in contact with a portion of user 210, worn by user 210, coupled to or positioned on a bedside table, coupled to a mattress, coupled to a ceiling, etc.).

[0073] User equipment 170 ( Figure 1 The system includes a display device 172. User device 170 may be, for example, a mobile device such as a mobile device, smartphone, tablet, laptop, etc. Alternatively, user device 170 may be an external sensing system, a television (e.g., a smart TV), or another smart home device (e.g., a smart speaker such as Google Home, Amazon Echo, Alexa, etc.). In some implementations, the user device is a wearable device (e.g., a smartwatch). Display device 172 is typically used to display images including still images, video images, or both. In some implementations, display device 172 acts as a human-machine interface (HMI) including a graphical user interface (GUI) configured to display images and provide input interfaces. Display device 172 may be an LED display, OLED display, LCD display, etc. Input interfaces may be, for example, a touchscreen or touch-sensitive substrate, a mouse, a keyboard, or any sensor system configured to sense input made by a human user interacting with the breathing device 170. In some implementations, system 100 may use and / or include one or more user devices.

[0074] Although the control system 110 and the memory device 114 are in Figure 1 While described and shown as separate and distinct components of system 100, in some implementations, control system 110 and / or memory device 114 are integrated into user equipment 170 and / or breathing device 122. Alternatively, in some implementations, control system 110 or a portion thereof (e.g., processor 112) may reside in the cloud (e.g., integrated into a server, integrated into an Internet of Things (IoT) device (e.g., smart TV, smart thermostat, smart appliance, smart lighting, etc.), connected to the cloud, subjected to edge cloud processing, etc.), or reside in one or more servers (e.g., remote server, local server, etc., or any combination thereof).

[0075] Although system 100 is shown as including all of the components described above, according to implementations of the invention, more or fewer components may be included in the system for generating physiological data and determining recommended notifications or actions for the user. For example, a first alternative system includes a control system 110, a storage device 114, and at least one of one or more sensors 130. As another example, a second alternative system includes a control system 110, a storage device 114, at least one of one or more sensors 130, and a user device 170. As yet another example, a third alternative system includes a control system 110, a storage device 114, a respiratory system 120, at least one of one or more sensors 130, and a user device 170. Therefore, various systems can be formed using any part or multiple parts of the components shown and described herein and / or in combination with one or more other components.

[0076] As used herein, sleep periods can be defined in various ways based on, for example, an initial start time and an end time. In some implementations, a sleep period is the duration of a user's sleep. In such an implementation, a sleep period has a start time and an end time, and during the sleep period, the user does not wake up until the end time. That is, any period during which the user is awake is not included in a sleep period. According to this first definition of a sleep period, if a user wakes up and falls asleep multiple times in the same night, each sleep interval separated by the wake-up intervals is a sleep period.

[0077] Alternatively, in some implementations, sleep periods have start and end times, and during a sleep period, the user can remain awake as long as the continuous duration of wakefulness is below a wakefulness duration threshold, without the sleep period ending. The wakefulness duration threshold can be defined as a percentage of the sleep period. For example, the wakefulness duration threshold can be approximately 20 percent, 15 percent, 10 percent, 5 percent, 2 percent, or any other threshold percentage. In some implementations, the wakefulness duration threshold is defined as a fixed amount of time, such as approximately one hour, approximately thirty minutes, approximately fifteen minutes, approximately ten minutes, approximately five minutes, approximately two minutes, or any other amount of time.

[0078] In some implementations, a sleep period is defined as the entire time between the time a user first goes to bed at night and the time the user last leaves bed the following morning. In other words, a sleep period can be defined as the time period that begins at a first time (e.g., 10:00 PM) on a first date (e.g., Monday, January 6, 2020), which can be referred to as the current night, when the user first enters bed intending to go to sleep (e.g., if the user does not intend to watch TV or use their smartphone before going to sleep), and ends at a second time (e.g., 7:00 AM) on a second date (e.g., Tuesday, January 7, 2020), which can be referred to as the following morning, when the user first leaves bed with the intention of not returning to sleep the following morning.

[0079] In some implementations, users can manually define the start and / or end of sleep periods. For example, a user can select (e.g., by clicking or tapping) an external device 170 ( Figure 1 The user-selectable elements displayed on user device 172 allow for the manual initiation or termination of sleep periods.

[0080] refer to Figure 3 This illustrates a method 300 for identifying whether a user has experienced insomnia during sleep. One or more steps of the method 300 described herein can be used with system 100 ( Figure 1 To achieve this.

[0081] Step 301 of method 300 includes receiving personal data associated with a user. For example, the personal data may be received and stored in a memory device 114 and / or user equipment 174 of user equipment 170. The personal data may be transmitted by the user via user equipment 170 (…). Figure 1The display device 172 is provided by an interface device and / or provided by a third party (e.g., a healthcare provider). Personal data may include medical data, such as information indicating that the user has been diagnosed with one or more medical conditions, medication use, or both (e.g., medical records). Personal data may include demographic data, such as information indicating the user's age, gender, race, employment status, education level, socioeconomic status, family history of insomnia, or any combination thereof. Personal data may also include subjective user data, including self-reported subjective sleep scores (e.g., poor, average, excellent), self-reported subjective fatigue levels, self-reported subjective stress levels, self-reported subjective health status (e.g., healthy or unhealthy), recent life events (e.g., changes in relationship status, birth of a child, death in the family, etc.), or any combination thereof. Personal data may also include information provided by a third party (e.g., medical records from a healthcare provider, questionnaires or feedback from family members or friends associated with the user, etc.). Personal data may further include Multisleep Waiting Time Test (MSLT) results or scores and / or Pittsburgh Sleep Quality Index (PSQI) scores or values. In some implementations, personal data also includes user-specified or recommended sleep times and / or wake times.

[0082] Step 302 of method 300 includes receiving physiological data associated with the user during at least a portion of a sleep period. At least one or more sensors 130 may be used. Figure 1 This generates or acquires physiological data. For example, in some implementations, a pressure sensor 132 and / or a flow sensor 134 are used. Figure 1 The device generates or acquires physiological data, with pressure and / or flow sensors coupled to or integrated into the breathing device 122. In other implementations, the microphone 140 described above is used to generate physiological data; the microphone is coupled to or integrated into the user device 170. Physiological data can be received from at least one of one or more sensors 130 via, for example, the electronic interface 119 described herein and / or the user device 170, and stored in memory 114. Figure 1 Physiological data can be received directly or indirectly (e.g., via one or more media) from at least one of one or more sensors 130 via electronic interface 119 or user equipment 170. Information describing the physiological data can be stored in memory device 114 and / or memory device 174 or user equipment 170.

[0083] Step 303 of method 300 includes analyzing the physiological data received during step 302 to determine the user's sleep-wake signals during a sleep period. As described above, the sleep-wake signals may indicate one or more sleep states, including wakefulness, relaxed wakefulness, micro-wakefulness, REM sleep, a first non-REM sleep stage, a second non-REM sleep stage, a third non-REM sleep stage, or any combination thereof. In some implementations, one or more of the first non-REM sleep stage, the second non-REM sleep stage, and the third non-REM sleep stage may be grouped together and classified as a light sleep stage or a deep sleep stage. For example, a light sleep stage may include a first non-REM sleep stage, while a deep sleep stage may include a second non-REM sleep stage and a third non-REM sleep stage. In other implementations, the sleep-wake signals may also indicate respiratory signals, respiratory rate, inspiratory amplitude, expiratory amplitude, inspiratory-expiratory ratio, number of events per hour, pattern of events, pressure setting of breathing device 122, or any combination thereof. Information describing the sleep-wake signals may be stored in memory device 114.

[0084] Reference Figure 4 In some implementations, step 303 may include generating a sleep graph 400 indicating sleep-wake signals. The sleep graph 400 may be displayed using a display device 172 of the user device 170. As shown, the sleep graph 400 includes sleep-wake signals 401 (step 303), a wakefulness stage axis 410, a REM stage axis 420, a light sleep stage axis 430, and a deep sleep stage axis 440. The sleep graph 400 also shows the bedtime t during sleep. 入床 Sleep time t GTS Initial sleep time t 睡 Awakening time t 醒 Wake-up time t 起床 First micro-awake MA1 and second micro-awake MA2. The intersection between sleep-wake signal 401 and one of axes 410-440 represents a sleep stage at any given time during a sleep period.

[0085] Although Figure 4 The sleep graph 400 shown includes a light sleep stage axis 430 and a deep sleep stage axis 440, but in some implementations, the sleep graph 400 may include axes for each of the first non-REM stage, the second non-REM stage, and the third non-REM stage.

[0086] Method 300 ( Figure 3Step 304 includes analyzing sleep-wake signals (step 303) to determine one or more sleep-related parameters associated with the user during the sleep period. As described herein, one or more sleep-related parameters may include bedtime, initial sleep time, wake time, wake-up time, total bedtime (TIB), total sleep time (TST), time to fall asleep (GTS), sleep wait time (SOL), wake-up after falling asleep (WASO) parameter, sleep efficiency (SE), segmentation index, sleep obstruction, hyperarousal, or any combination thereof.

[0087] Bedtime is associated with the time when a user (e.g., when the user lies down or sits in bed) initially enters bed (e.g., bed 240) to begin a sleep period. For example, see reference... Figure 4 On the sleep graph 400, the bedtime is represented as time t. 入床 The bed-entry time t can be determined based on data generated, for example, by motion sensor 138, microphone 140 and speaker 142, camera 150 or any combination thereof. 入床 .

[0088] Wake-up time is the time when a user wakes up without returning to sleep (e.g., the opposite of a user waking up at night and returning to sleep). Similarly, wake-up time is the time when a user gets out of bed and exits the bed to end a sleep period (e.g., the opposite of a user getting up at night to go to the bathroom, walk the dog, care for children, sleepwalk, etc.). See reference. Figure 4 On sleep graph 400, wakefulness time is shown as time t. 醒 The wake-up time is displayed as time t. 起床 .

[0089] Total Time in Bed (TIB) is the duration between the time the user goes to bed and the time the user wakes up, as described above. Therefore, in most cases, TIB includes one or more time periods when the user is asleep and one or more time periods when the user is not asleep (e.g., the time between the user falling asleep after entering bed, the time between wakefulness and wakefulness, etc.). For example, Figure 5 The diagram shows the time to bed arrival (t) 入床 ), initial sleep time (t) 睡 ), Awakening time (t) 醒 ), wake-up time (t) 起床 Example timeline 501 for bed entry time and total bed time (TIB). Total bed time (TIB) is the time from bed entry to bed entry time t. 入床 and wake-up time t 起床 The duration between.

[0090] Total sleep time (TST) is the duration between initial sleep time and wake time, excluding any conscious or unconscious awakenings and / or micro-awakenings in between. Typically, the total sleep time parameter will be shorter than the total bedtime parameter (e.g., one minute shorter, ten minutes shorter, one hour shorter, etc.). For example, refer to... Figure 5 Timeline 501, Total Sleep Time (TST) spanning initial sleep time t 睡 and awakening time t 醒 The duration of total sleep time (TST) is between the durations of first micro-awake (MA1) and second micro-awake (MA2), excluding the durations of these two micro-awakes. As shown in the figure, in this example, total sleep time (TST) is shorter than total bedtime (TIB).

[0091] In some implementations, total sleep time can be defined as persistent total sleep time (PTST). In this implementation, persistent total sleep time excludes a predetermined initial portion or period of the first non-REM stage (e.g., a light sleep stage). For example, the predetermined initial portion could be between approximately 30 seconds and approximately 20 minutes, between approximately 1 minute and approximately 10 minutes, between approximately 3 minutes and approximately 5 minutes, etc. Persistent total sleep time is a measure of continuous sleep and smooths the sleep-wake sleep graph. For example, when a user initially falls asleep, the user may be in the first non-REM stage for a very short time (e.g., 30 seconds), then return to the wake stage for a very short time (e.g., one minute), and then return to the first non-REM stage. In this example, persistent total sleep time excludes the first instance of the first non-REM stage (30 seconds). Presenting a smooth sleep graph based on persistent total sleep time (PTST) (e.g., sleep graph 400) can be useful because users may be more familiar with longer blocks of sleep stages (e.g., because users do not remember how they fell asleep).

[0092] The time to fall asleep (GTS) is associated with the time when a user first attempts to fall asleep. For example, after going to bed, a user can engage in one or more activities to relax before trying to sleep (e.g., reading, watching TV, listening to music, using user device 170...). Figure 1 (etc.). In other words, bedtime is usually different from sleeptime. Sleeptime can be determined based on, for example, data from motion sensor 138 (e.g., data indicating that the user is not moving), data from camera 150 (e.g., data indicating that the user is not moving and / or that the user has turned off the lights), data from microphone 140 (e.g., data indicating that the TV is being turned off), data from user device 170 (e.g., data indicating that the user is no longer using user device 170), data from pressure sensor 132 and / or flow sensor 134 (e.g., data indicating that the user turns on breathing device 122, data indicating that the user wears user interface 124, etc.), or any combination thereof.

[0093] Sleep latency (SOL) is the duration between the time it takes to fall asleep and the initial sleep time described above. As further described in detail herein, sleep latency can be used to determine whether a user experiences insomnia during sleep (e.g., sleep onset insomnia). Reference Figure 5 Timeline 501, Sleep Onset Time (SOL) includes time to fall asleep (t) GTS ) and initial sleep time (t 睡 The time between ).

[0094] In some implementations, the sleep-on-fall time is defined as the continuous sleep-on-fall time (PSOL). The difference between PSOL and sleep-on-fall time is that PSOL is defined as the duration between the time of falling asleep and a predetermined amount of continuous sleep. In some implementations, the predetermined amount of continuous sleep may include, for example, at least 10 minutes of sleep within a second non-REM stage, a third non-REM stage, and / or a REM stage (with awakenings of no more than 2 minutes), a first non-REM stage, and / or transitions between them. In other words, continuous sleep of up to, for example, 8 minutes within the second non-REM stage, the third non-REM stage, and / or the REM stage and / or the REM stage. In other implementations, the predetermined amount of continuous sleep may include at least 10 minutes of sleep within a first non-REM stage, a second non-REM stage, a third non-REM stage, and / or a REM stage after the initial sleep time. In such implementations, the predetermined amount of continuous sleep may exclude any micro-awakenings (e.g., a ten-second micro-awakening does not restart the 10-minute period).

[0095] Post-sleep wake-onset (WASO) is associated with the total duration of a user's wakefulness between initial sleep and wakefulness. Therefore, WASO includes brief and micro-awake periods during sleep (e.g., Figure 4 The micro-awakenings (MA1 and MA2) shown can be either conscious or unconscious. In some implementations, a sleep-wake attack (WASO) is defined as a sustained sleep-wake attack (PWASO) that consists only of a total duration of awakenings having a predetermined length (e.g., greater than 10 seconds, greater than 30 seconds, greater than 60 seconds, greater than about 5 minutes, greater than about 10 minutes, etc.).

[0096] Sleep efficiency (SE) is defined as the ratio of total time spent in bed (TIB) to total sleep time (TST). For example, if the total time spent in bed is 8 hours and the total sleep time is 7.5 hours, then the sleep efficiency for that sleep period is 93.75%. Sleep efficiency reflects a user's sleep hygiene. For example, if a user goes to bed before sleep and spends time engaging in other activities (e.g., watching television), sleep efficiency will decrease (e.g., the user is penalized).

[0097] In some implementations, sleep efficiency (SE) can be calculated based on total time in bed (TIB) and the total time the user attempted to sleep. In such implementations, the total time the user attempted to sleep is defined as the duration between the time to fall asleep (GTS) and the wake-up time described here. For example, if the total sleep time is 8 hours (e.g., between 11 PM and 7 AM), the time to fall asleep is 10:45 AM, and the wake-up time is 7:15 AM, then in such an implementation, the sleep efficiency parameter is calculated to be approximately 94%.

[0098] The segmentation index is determined at least in part based on the number of awakenings during sleep periods. For example, if a user has two micro-awakes (e.g., Figure 4 As shown in the micro-awakenings MA1 and MA2, the segmentation index can be represented as 2. In some implementations, the segmentation index is scaled between a predetermined range of integers (e.g., between 0 and 10).

[0099] Sleep blocks are associated with the transition between any sleep stage (e.g., first non-REM stage, second non-REM stage, third non-REM stage, and / or REM stage) and the waking stage. Sleep blocks can be calculated at a resolution of, for example, 30 seconds.

[0100] As described herein, hyperarousal is characterized by increased physiological activity and can indicate a user's stress level. Therefore, in some implementations, step 304 includes determining the user's level of hyperarousal based on sleep-wake signals (step 303), physiological data (step 302), and / or personal data (step 301). For example, the level of hyperarousal can be determined by comparing the user's self-reported subjective stress level (step 301) included in personal data with previously recorded subjective stress levels and / or demographic standards. In another example, the level of hyperarousal can be determined based on the user's breathing during sleep periods (e.g., respiratory rate, respiratory variability, respiratory duration, respiratory interval, average respiratory rate, breathing during each sleep stage). For another example, the level of hyperarousal can be determined based on the user's movement during sleep periods (e.g., based on data from motion sensor 138). In yet another example, the level of hyperarousal can be determined based on the user's heart rate data during sleep or daytime.

[0101] Step 305 of method 300 includes determining whether the user experiences insomnia during sleep. In some implementations, step 305 of method 300 includes identifying the type of insomnia experienced by the user and / or identifying one or more insomnia symptoms experienced by the user. Types of insomnia include, for example, persistent or chronic insomnia, acute insomnia, sleep onset insomnia, sleep maintenance insomnia, early awakening, mixed insomnia, comorbid insomnia, and paradoxical insomnia. For example, step 305 may include comparing one or more sleep-related parameters (step 305) with predetermined thresholds to identify whether the user has experienced insomnia, including specific types of insomnia.

[0102] In some implementations, step 305 includes determining whether the user experienced sleep insomnia during the sleep period by comparing the aforementioned sleep onset wait time (SOL) or sustained sleep onset wait time (PSOL) with a predetermined threshold associated with sleep insomnia. In such implementations, the predetermined threshold may be, for example, between about 15 minutes and about 60 minutes, between about 20 minutes and about 30 minutes, at least 20 minutes, at least 30 minutes, at least 45 minutes, etc. Preferably, the sleep onset wait time (SOL) is compared with a predetermined threshold of about 30 minutes, and the sustained sleep onset wait time (PSOL) is compared with a predetermined threshold of about 20 minutes. If the sleep onset wait time is equal to or exceeds the predetermined threshold, the control system 110 determines that the user experienced sleep insomnia during the sleep period. Conversely, if the sleep onset wait time does not exceed the predetermined threshold, the control system 110 determines that the user did not experience sleep insomnia.

[0103] In some implementations, step 305 includes determining, at least in part, that the user experienced sleep maintenance insomnia during the sleep period based on post-sleep wakefulness onset (WASO), total sleep time (TST), sleep efficiency (SE), sleep block, or any combination thereof. More specifically, each of these sleep-related parameters can be compared to a predetermined threshold associated with sleep maintenance insomnia. The predetermined threshold can be stored in the user device 170 (…). Figure 1 In memory device 114 and / or memory device 172.

[0104] For example, step 305 may include comparing the sleep-after-wake start (WASO) or continuous sleep-after-wake start (PWASO) with predetermined thresholds, such as between about 5 minutes and about 60 minutes, between about 15 minutes and about 45 minutes, greater than about 20 minutes, greater than about 30 minutes, greater than about 45 minutes, etc. For instance, comparing the sleep-after-wake start (WASO) with a predetermined threshold of about 30 minutes, and comparing the continuous sleep-after-wake start (PWASO) with a predetermined threshold of about 45 minutes.

[0105] As another example, step 305 may include comparing the total sleep time (TST) to a predetermined threshold, which is between approximately 3 hours and approximately 7 hours, between approximately 4 hours and approximately 6.5 hours, at least 4 hours, at least 5 hours, at least 6 hours, at least 6.5 hours, etc. If the total sleep time (TST) is not equal to or exceeds the predetermined threshold, the control system 110 determines that the user experienced sleep maintenance insomnia during the sleep period.

[0106] In another example, step 305 may include comparing sleep efficiency (SE) to a predetermined threshold, which is between about 50% and about 100%, between about 75% and about 90%, at least about 75%, at least about 85%, at least about 90%, etc. If sleep efficiency (SE) is not equal to or exceeds the predetermined threshold, the control system 110 determines that the user experienced sleep maintenance insomnia during the sleep period.

[0107] As another example, step 305 may include comparing a sleep segmentation index to one or more predetermined thresholds, including a predetermined number of awakenings (e.g., more than 3 awakenings, more than 5 awakenings, more than 10 awakenings, etc.) and / or a predetermined duration of each awakening (e.g., at least 15 seconds, at least 30 seconds, at least one minute, at least 3 minutes, etc.). If the sleep segmentation index exceeds the predetermined thresholds, the control system 110 determines that the user has experienced sleep maintenance insomnia during the sleep period.

[0108] In some implementations, step 305 includes determining, at least in part, that the user has experienced early awakening based on wake-up time, wake-up time, target or desired wake-up time, target or desired wake-up time, or any combination thereof. As described above, early awakening occurs when a user wakes up and is unable to return to sleep. For example, step 305 may include comparing the duration between wake-up time and wake-up time with a predetermined threshold for early awakening (e.g., at least 20 minutes, at least 30 minutes, at least 60 minutes, etc.). If the duration between wake-up time and wake-up time exceeds the predetermined threshold, the control system 110 determines that the user has experienced early awakening. In another example, step 305 may include comparing the wake-up time with a target or desired wake-up time (which may be received as part of personal data in step 301). If the difference between the wake-up time and the target or desired wake-up time exceeds a predetermined threshold (e.g., at least 20 minutes, at least 30 minutes, at least 45 minutes, at least 60 minutes, etc.), the control system 110 determines that the user has experienced early awakening. In another example, step 305 may include comparing the wake-up time with a target or desired wake-up time (which may be received as part of personal data during step 301). If the difference between the wake-up time and the target or desired wake-up time exceeds a predetermined threshold (e.g., at least 20 minutes, at least 30 minutes, at least 45 minutes, at least 60 minutes, etc.), the control system 110 determines that the user has experienced early awakening.

[0109] In some implementations, step 305 includes at least partially based on storage in memory device 114 ( Figure 1 The received personal data is used to determine whether the user experiences comorbid insomnia and / or pharmacological / therapeutic insomnia (step 301). In such an implementation, step 305 includes determining whether the personal data includes information indicating one or more medical conditions and / or prescription medication use associated with comorbid insomnia. For example, certain prescription medications used to treat depression, pain, and / or inflammation are known to be associated with insomnia-related symptoms. If the personal data indicates that the user has a medical condition or is using prescription medications associated with comorbid insomnia, and if the control system 110 determines that the user experienced sleep onset insomnia, sleep maintenance insomnia, and / or early awakening, then the control system 110 determines that the user experienced comorbid insomnia during sleep periods.

[0110] In some implementations, step 305 includes determining, at least in part, that the user has experienced anomalous insomnia based on personal data received during step 301. As described above, personal data may include self-reported subjective sleep scores (e.g., poor, average, excellent), self-reported subjective fatigue levels, self-reported subjective stress levels, and / or self-reported subjective health status. Anomalous insomnia occurs when the user's perceived sleep quality differs from actual sleep-wake data. For example, if the self-reported subjective sleep score is poor (step 301), while the total sleep time meets or exceeds a predetermined threshold (e.g., 8 hours of sleep), the control system 110 may determine that the user has experienced anomalous insomnia.

[0111] In some implementations, step 305 includes determining that the user experienced mixed insomnia. Mixed insomnia occurs when a user has a combination of attributes including insomnia onset, insomnia on sleep maintenance, and / or early awakening. Thus, for example, as described above, if the control system 110 determines that the user experienced two or more of the following: insomnia onset, insomnia on sleep maintenance, and early awakening, the control system 110 can determine that the user experienced mixed insomnia during sleep periods.

[0112] In some implementations, step 305 may further include determining, at least in part, that the user experienced another sleep-related disorder (in addition to insomnia) during the sleep period based on sleep-wake signals (step 303) and sleep-related parameters (step 304). For example, step 305 may include determining that the user experienced one or more of the following: periodic limb movement disorder (PLMD), obstructive sleep apnea (OSA), Cheyne-Stokes respiration (CSR), respiratory insufficiency, obesity-related hyperventilation syndrome (OHS), chronic obstructive pulmonary disease (COPD), neuromuscular disease (NMD), chest wall disorder, snoring, apnea, hypopnea, restless legs syndrome, sleep disturbance, apnea, increased heart rate, dyspnea, asthma attack, seizure, convulsion, or any combination thereof. Therefore, method 300 can be used to differentiate insomnia from other sleep-related conditions to avoid false positives for insomnia.

[0113] In some implementations, step 305 includes using a machine learning algorithm to determine if the user experienced insomnia during their sleep period. For example, step 305 may include using a neural network (e.g., a shallow or deep method) to determine if the user experienced insomnia and to identify the type of insomnia.

[0114] In some implementations, method 300 further includes generating a report or responding to determining that the user experienced insomnia during a sleep period. For example, the report may provide information indicating the type of insomnia identified during step 305 (e.g., sleep onset insomnia, sleep maintenance insomnia, or early awakening) and / or information indicating one or more sleep-related parameters determined during step 305. The report may be stored in the memory device 114 of the control system 110 and / or the user device 170. Figure 1 The data is stored in the memory device 174, displayed on the display device 172 of the user device 170, and / or sent to a third party (e.g., a medical provider).

[0115] Method 300 may also include generating recommended personalized treatments or actions for the user in response to determining that the user experienced insomnia during a sleep period (step 305) or that the user experienced different sleep-related conditions during a sleep period. For example, method 300 may include recommending changes in sleep habits or health maintenance, recommending sleep medicine and / or pharmaceutical treatments, recommending cognitive behavioral therapy, or any combination thereof. As mentioned above, the personal data received during step 301 may include information indicating the user's stress or anxiety levels and self-reported subjective feedback. Therefore, the recommended treatment can be personalized to suggest one or more treatments that may be effective without increasing the user's anxiety or stress levels. The recommended treatment may also be personalized based on the user's tendency to adhere to treatment, as determined based on the received personal data. Personalized treatment can help connect users to appropriate treatments to address specific conditions (thus reducing reliance on sleep labs and physicians) and generally improve the user's quality of life.

[0116] In some implementations, method 300 also includes regulating the respiratory system 120 at least in part based on the determined type of insomnia. Figure 2 One or more settings of the breathing device 122 (step 305) can be adjusted to help reduce insomnia symptoms. For example, such implementation may include adjusting the pressure settings of the breathing device 122 (e.g., decreasing the pressure setting, adjusting the pressure rise, prolonging the delivery of pressurized air, etc.).

[0117] refer to Figure 6 This illustrates a method 600 for identifying whether a user experiences insomnia during multiple sleep periods. One or more steps of the method 600 described herein can be used with system 100 (… Figure 1 To achieve this.

[0118] Step 601 of method 600 is the same as step 601 of method 300. Figure 3Step 301 is the same as or similar to that of the method described above, and includes receiving personal data associated with the user. Personal data may include medical data, such as information indicating one or more medical conditions, medication use, or both. Personal data may include demographic data, such as information indicating the user's age, gender, ethnicity, employment status, education level, socioeconomic status, family history of insomnia, or any combination thereof. Personal data may also include subjective user data, including self-reported subjective sleep scores (e.g., poor, average, excellent), self-reported subjective fatigue levels, self-reported subjective stress levels, self-reported subjective health status (e.g., healthy or unhealthy), recent life events (e.g., changes in relationship status, birth of a child, death in the family, etc.), or any combination thereof. In some implementations, personal data may also include a target or desired sleep onset time and / or a target or desired wake-up time specified or recommended by the user.

[0119] Step 602 of method 600 is the same as that of method 300. Figure 3 Step 302 is the same as or similar to that of the first sleep period and includes receiving first physiological data associated with the user during the first sleep period. For example, step 602 may include receiving data from one or more sensors 130 described herein. Figure 1 At least the first sensor in the respiratory device 122 receives the first physiological data. In some implementations, the first sensor used during step 602 is coupled to or integrated into the respiratory device 122 (e.g., the first sensor includes a pressure sensor 132 and / or a flow sensor 134).

[0120] Step 603 of method 600 is the same as step 603 of method 300. Figure 3 Step 303 is the same as or similar to step 602, and includes analyzing first physiological data to determine sleep-wake signals associated with the user during the first sleep period. As described herein, step 603 may include generating a sleep graph (e.g., with) displaying sleep-wake signals. Figure 4 The sleep diagram shown is the same as or similar to the sleep diagram 400.

[0121] Step 604 of method 600 is the same as that of method 300. Figure 3 Step 304 is the same as or similar to that of the previous step and includes determining at least a first sleep-related parameter associated with the user during the first sleep period, at least in part based on sleep-wake signals (step 603). As described herein, the first sleep-related parameter may include, for example, bedtime, initial sleep time, wake-up time, wake-up time, total bedtime (TIB), total sleep time (TST), time to fall asleep (GTS), sleep wait time (SOL), wake-up after falling asleep (WASO) parameter, sleep efficiency (SE), segmentation index, sleep blockage, or any combination thereof.

[0122] Step 605 of method 600 is the same as step 605 of method 300. Figure 3 Step 305 is the same as or similar to that of the first sleep period and includes determining, at least in part, whether the user experienced insomnia during the first sleep period based on personal data (step 601) and / or first sleep-related parameters (step 604). For example, as described herein, step 605 may include determining that the user experienced sleep onset insomnia, sleep maintenance insomnia, early awakening, comorbid insomnia, etc.

[0123] Step 606 of method 600 includes receiving second physiological data associated with the user using at least a second sensor after the first sleep period but before the second subsequent sleep period. In some implementations, a second sensor, different from the first sensor, may be used to generate or acquire the second physiological data. For example, in such an implementation, the first sensor (step 602) may be coupled to or integrated into the breathing device 122. Figure 1 The second sensor is connected to or integrated into the user equipment 170. The second physiological data is the same as or similar to the first physiological data (step 602), but is generated or obtained during a day rather than during the first sleep period.

[0124] Step 607 of method 600 includes analyzing second physiological data (step 606) to identify one or more daytime symptoms experienced by the user. As described herein, certain insomnia symptoms can be characterized as daytime symptoms, such as fatigue, decreased energy, cognitive impairment (e.g., attention, concentration, and / or memory), difficulty functioning in academic or professional settings, and / or mood disturbances. For example, step 607 may include using the second physiological data to determine the user's activity level throughout the day and comparing the determined activity level to a predetermined threshold to determine whether the user experiences fatigue symptoms during the day. As another example, step 607 may include determining the user's reaction time (e.g., in response to stimuli) and comparing the determined reaction time to a predetermined threshold to determine whether the user experienced cognitive impairment symptoms during the day.

[0125] In some implementations, step 607 includes receiving subjective user report feedback associated with the first sleep period. For example, the user can provide feedback after the first sleep period (e.g., using user device 170). Figure 1 This describes information such as self-reported subjective sleep scores (e.g., poor, average, excellent), self-reported subjective fatigue levels, and self-reported subjective stress levels. Users can also provide, for example, target or desired sleep onset time and / or target or desired wake-up time for a second follow-through sleep period.

[0126] Step 608 of method 600 includes adjusting a predetermined threshold used during step 605 to determine whether the user experiences insomnia during the first sleep period. This adjustment may be based at least in part on the identification of insomnia during the first sleep period (step 605), insomnia symptoms identified during step 607, or both. Adjustment may include increasing or decreasing the predetermined threshold.

[0127] For example, as described above, the determined sleep latency (SOL) can be compared to a predetermined threshold to determine whether the user is experiencing sleep insomnia (e.g., if the sleep latency exceeds the threshold). In some implementations, adjustments include lowering the predetermined threshold to compare with the sleep latency of a second sleep period (e.g., reducing the threshold from approximately 30 minutes to approximately 20 minutes). For example, the predetermined threshold can be lowered at least in part based on identified daytime symptoms and / or the aforementioned self-reported subjective feedback. If the user is severely fatigued during the day, the user should fall asleep faster than when the user is not fatigued during the day. Therefore, in this case, the predetermined threshold can be lowered to address the fact that the user is experiencing sleep insomnia.

[0128] As another example, as described above, the determined Post-Sleep Wake-Up Start (WASO) can be compared to a predetermined threshold to determine whether the user is experiencing sleep maintenance insomnia (e.g., if WASO exceeds the threshold). In some implementations, adjustment includes lowering the predetermined threshold to be compared with WASO in response to determining that the user is not experiencing sleep maintenance insomnia during the first sleep period (e.g., lowering the threshold from about 30 minutes to about 15 minutes). Alternatively, as described above, the determined Total Sleep Time (TST) can be compared to a predetermined threshold to determine whether the user is experiencing sleep maintenance insomnia (e.g., if TST is below the threshold). In some implementations, adjustment includes raising or lowering the threshold in part based on identified insomnia symptoms (step 607). For example, if it is determined that the user is fatigued during the day following the first sleep period, the threshold to be compared with TST can be lowered to determine whether the user is experiencing insomnia during the second sleep period (step 612).

[0129] Step 609 of method 600 is the same as or similar to step 602, and includes receiving third physiological data associated with the user using the first sensor described above during the second sleep period. Alternatively, the third physiological data may be generated or acquired using a different sensor than the one used to generate or acquire the first physiological data (step 602).

[0130] Step 610 of method 600 is the same as or similar to step 603 described above, and includes analyzing third physiological data to determine a second sleep-wake signal associated with the user during the second sleep period. Similar to the first sleep-wake signal (step 602), the second sleep-wake signal for the second sleep period can be plotted against sleep graph 400 ( Figure 4 The same or similar sleep patterns. In some implementations, method 600 includes using, for example, user device 170 ( Figure 1 The display device 172 simultaneously displays a first sleep graph of the first sleep-wake signal (step 603) and a second sleep graph of the second sleep-wake signal (step 610).

[0131] Step 611 of method 600 is the same as or similar to step 604 described above, and includes determining at least a second sleep-related parameter associated with the user during the second sleep period. The second sleep-related parameter (step 611) may be the same as or different from the first sleep-related parameter (step 604).

[0132] Step 612 of method 600 is the same as or similar to step 605 described above, and includes determining, at least in part, whether the user experiences insomnia during the second sleep period based on an adjusted predetermined threshold (step 605). Because the predetermined threshold is adjusted between the first and second sleep periods (step 605), the identifier in step 612 may differ from the identifier in step 605 even for the same sleep-related parameter values.

[0133] Although this document describes method 600 for two sleep periods, the steps of method 600 can be repeated once or multiple times for any number of sleep periods (e.g., three sleep periods, ten sleep periods, fifty sleep periods, one hundred sleep periods, etc.).

[0134] In summary, the systems and methods described herein can be used to assist individuals with adverse physiological conditions (e.g., lower performance, slower reaction time, increased risk of depression, anxiety, etc.) and those with other adverse physiological conditions (e.g., high blood pressure, increased risk of heart disease, poor immune system function, obesity, etc.) by automatically identifying that they experienced insomnia during sleep, rather than other sleep-related illnesses or problems. These systems and methods categorize the type of insomnia experienced by a user based on physiological data and the user's subjective experience, allowing for personalized treatment pathways. These and other benefits reduce reliance on medication and its associated disadvantages (e.g., side effects and / or dependence) and reduce the burden on busy clinicians and sleep laboratories.

[0135] One or more elements, aspects, or steps or any part thereof from any one of claims 1-54 may be combined with one or more elements, aspects, or steps or any part thereof from any other claims 1-54 or a combination thereof to form one or more additional implementations and / or claims of the present invention.

[0136] While the invention has been described with reference to one or more specific embodiments and implementations, those skilled in the art will recognize that many changes can be made thereto without departing from the spirit and scope of the invention. Each of these implementations and their obvious variations is considered to fall within the spirit and scope of the invention. Additional implementations of aspects of the invention are also contemplated, combining any number of features from any of the implementations described herein.

Claims

1. A system for screening and managing insomnia, comprising: One or more sensors configured to generate first physiological data associated with a user during a first sleep period, the one or more sensors including a pressure sensor configured to generate pressure data indicating the user's breathing; The treatment system includes: Breathing equipment, configured to supply pressurized air; and A user interface, which is connected to the breathing device via a catheter, is configured to engage with a portion of the user during the first sleep period to help direct supplied pressurized air into the user's airway; Memory that stores machine-readable instructions; and The control system includes one or more processors configured to execute the machine-readable instructions, to: The sleep-wake signals of the user during the first sleep period are determined at least in part based on the first physiological data, and the sleep-wake signals are determined at least in part based on the stress data; One or more sleep-related parameters of the user during the first sleep period are determined at least in part based on the sleep-wake signals, the one or more sleep-related parameters including at least a sleep onset wait time, which is determined as a function of sleep onset time and initial sleep time; Whether the user experienced insomnia during the first sleep period is determined by comparing at least one of the one or more sleep-related parameters with a predetermined threshold. In response to determining that the user experienced insomnia during the first sleep period, the type of insomnia experienced by the user is identified at least in part based on the one or more sleep-related parameters, the type of insomnia including at least sleep onset insomnia; The adjustment of one or more settings of the treatment system is determined at least in part based on the identified type of insomnia, and the adjustment of the one or more settings of the treatment system includes adjusting the pressure settings of the breathing device at least in part based on the pressure data; One or more settings of the treatment system are adjusted, at least in part, based on the identified type of insomnia; Receive second physiological data associated with the user after the first sleep period; and The predetermined threshold is adjusted to an adjusted threshold based at least in part on the second physiological data.

2. The system of claim 1, wherein the one or more sensors include a first sensor configured to generate at least a portion of the first physiological data, wherein the first sensor is connected to or integrated into the treatment system.

3. The system of claim 1, wherein the one or more sensors comprise: A first sensor, configured to generate a first portion of the first physiological data; And a second sensor, which is configured to generate a second portion of the first physiological data.

4. The system of claim 3, wherein the first sensor is connected to or integrated into the respiratory device of the treatment system, and the second sensor is connected to or integrated into the user device.

5. The system of claim 4, wherein the user equipment is a mobile device or a television, the mobile device including a smartphone, tablet, laptop, or wearable device.

6. The system of claim 1, wherein adjusting the pressure setting includes decreasing the pressure setting, adjusting the pressure rise, or extending the delivery of pressurized air.

7. The system of claim 1, wherein the sleep-wake signal indicates one or more sleep stages during the first sleep period, the one or more sleep stages comprising a wake stage, a first non-REM stage, a second non-REM stage, a third non-REM stage, a REM stage, or any combination thereof.

8. The system of claim 1, wherein the one or more sleep-related parameters further include total sleep time, total time in bed, time to fall asleep, initial sleep time, continuous sleep onset time, wake-up parameters after falling asleep, continuous wake-up parameters after falling asleep, sleep efficiency, segmentation index, or any combination thereof.

9. The system of claim 8, wherein identifying the type of insomnia includes determining that the sleep latency is equal to or greater than a predetermined sleep latency threshold.

10. The system of claim 8, wherein the type of insomnia further includes sleep maintenance insomnia, and identifying the type of insomnia includes determining that the post-sleep wakefulness parameter is equal to or greater than a predetermined threshold, or determining that the sleep efficiency is equal to or less than a predetermined threshold.

11. The system of claim 1, wherein the control system is further configured to determine that the user experienced different sleep-related disorders during the sleep period, wherein the different sleep-related disorders are central apnea, obstructive apnea, mixed apnea, hypopnea with snoring, periodic limb movement, restless legs syndrome, suffocation, increased heart rate, dyspnea, asthma attack, seizure, convulsion, or any combination thereof.

12. The system of claim 1, wherein the control system is further configured to receive personal data associated with the user and to identify the type of insomnia based at least in part on the personal data.

13. The system of claim 1, wherein the control system is further configured to: (i) determine a recommended action for the user based on the identified type of insomnia to help reduce or prevent insomnia symptoms in a second subsequent sleep period, and (ii) display an instruction indicating the recommended action on a display device, wherein the recommended action includes a suggested bedtime, a suggested wake-up time, a suggested diet, a suggested exercise routine, a suggested sleep medication, a suggested relaxation procedure, a suggested masking noise, a suggested breathing procedure, a suggested change in bedroom activity, or any combination thereof.

14. The system of claim 1, wherein the one or more sensors are configured to generate: (i) second physiological data associated with the user after the first sleep period and before the second sleep period; and (ii) third physiological data associated with the user during the second sleep period.

15. The system of claim 14, wherein the control system is further configured to determine, at least in part, a second sleep-wake signal associated with the second sleep period based on the third physiological data, determine, at least in part, a second sleep-related parameter associated with the second sleep period based on the second sleep-wake signal, and determine, at least in part, whether the user experiences insomnia during the second sleep period based on the second sleep-related parameter.

16. The system of claim 15, wherein the control system is further configured to determine whether the user experiences insomnia during the second sleep period by comparing the second sleep-related parameter with the adjusted threshold.

17. A computer-implemented method for using a control system to monitor sleep-related data and determine operating parameters of a respiratory therapy system, the computer-implemented method comprising: The control system receives first physiological data associated with the user during a first sleep period, the first physiological data including pressure data indicating the user’s breathing in the respiratory therapy system. The control system determines the user's sleep-wake signals during the first sleep period based at least in part on the received first physiological data and the stress data. The control system determines one or more sleep-related parameters of the user during the first sleep period, based at least in part on the sleep-wake signals. The control system determines whether the user experienced insomnia during the first sleep period by comparing at least one of the one or more sleep-related parameters with a predetermined threshold. The one or more sleep-related parameters include at least a sleep onset time, which is determined as a function of sleep onset time and initial sleep time. In response to determining that the user experienced insomnia during the first sleep period, the control system identifies the type of insomnia experienced by the user based at least in part on the one or more sleep-related parameters, the type of insomnia including at least sleep onset insomnia; The control system determines the adjustment of one or more settings of the respiratory therapy system based at least in part on the identified type of insomnia; The control system receives second physiological data associated with the user after the first sleep period. as well as The predetermined threshold is adjusted to an adjusted threshold by the control system based at least in part on the second physiological data.

18. The computer-implemented method of claim 17, wherein the sleep-wake signal indicates one or more sleep stages during the sleep period, the one or more sleep stages comprising a wakefulness stage, a first non-REM stage, a second non-REM stage, a third non-REM stage, a REM stage, or any combination thereof, and wherein the one or more sleep-related parameters further comprise total sleep time, total bedtime, sleep onset time, initial sleep time, sustained sleep onset time, sleep onset wakefulness parameter, sustained sleep onset wakefulness parameter, sleep efficiency, segmentation index, or any combination thereof.

19. The computer-implemented method of claim 18, wherein the identified type of insomnia is sleep onset insomnia, and identifying the type of insomnia includes determining that the sleep onset waiting time is equal to or greater than a predetermined sleep onset waiting time threshold.

20. The computer-implemented method of claim 18, wherein the type of insomnia further includes sleep maintenance insomnia, and identifying the type of insomnia includes determining that the post-sleep wakefulness parameter is equal to or greater than a predetermined post-sleep wakefulness threshold.

21. A system for screening and managing insomnia, comprising: An electronic interface configured to receive first physiological data associated with the user during the first sleep period; Memory that stores machine-readable instructions; as well as The control system includes one or more processors configured to execute the machine-readable instructions, to: The sleep-wake signals of the user during the first sleep period are determined at least in part based on the first physiological data; The sleep-wake signal is used to determine one or more sleep-related parameters of the user during the first sleep period, at least in part, and the one or more sleep-related parameters include total sleep time, total time in bed, time to fall asleep, initial sleep time, sleep onset time, continuous sleep onset time, wake-up parameters after falling asleep, continuous wake-up parameters after falling asleep, sleep efficiency, segmentation index, or any combination thereof. Whether the user experienced insomnia during the first sleep period is determined by comparing at least one of the one or more sleep-related parameters with a predetermined threshold. In response to determining that the user experienced insomnia during the first sleep period, the type of insomnia experienced by the user is identified at least in part based on the one or more sleep-related parameters, wherein the type of insomnia is sleep maintenance insomnia, and wherein identifying the type of insomnia includes determining that the post-sleep wakefulness parameter is equal to or greater than a predetermined post-sleep wakefulness threshold. The adjustment of one or more settings of the respiratory therapy system is determined at least in part based on the identified type of insomnia, and the adjustment of the one or more settings of the respiratory therapy system includes adjusting the pressure setting of the breathing device; One or more settings of the respiratory therapy system are adjusted, at least in part, based on the identified type of insomnia; Receive second physiological data associated with the user after the first sleep period; as well as The predetermined threshold is adjusted to an adjusted threshold based at least in part on the second physiological data.

22. A system for screening and managing insomnia, comprising: An electronic interface configured to receive first physiological data associated with the user during the first sleep period; Memory that stores machine-readable instructions; as well as The control system includes one or more processors configured to execute the machine-readable instructions, to: The sleep-wake signals of the user during the first sleep period are determined at least in part based on the first physiological data; The sleep-wake signal is used to determine one or more sleep-related parameters of the user during the first sleep period, at least in part, and the one or more sleep-related parameters include total sleep time, total time in bed, time to fall asleep, initial sleep time, sleep onset time, continuous sleep onset time, wake-up parameters after falling asleep, continuous wake-up parameters after falling asleep, sleep efficiency, segmentation index, or any combination thereof. Whether the user experienced insomnia during the first sleep period is determined by comparing at least one of the one or more sleep-related parameters with a predetermined threshold. as well as In response to determining that the user experienced insomnia during the first sleep period, the type of insomnia experienced by the user is identified at least in part based on the one or more sleep-related parameters, wherein the type of insomnia is sleep maintenance insomnia, and wherein identifying the type of insomnia includes determining that the sleep efficiency is equal to or less than a predetermined sleep efficiency threshold. The adjustment of one or more settings of the respiratory therapy system is determined at least in part based on the identified type of insomnia, and the adjustment of the one or more settings of the respiratory therapy system includes adjusting the pressure setting of the breathing device; One or more settings of the respiratory therapy system are adjusted, at least in part, based on the identified type of insomnia; Receive second physiological data associated with the user after the first sleep period; as well as The predetermined threshold is adjusted to an adjusted threshold based at least in part on the second physiological data.

Citation Information

Patent Citations

  • Apparatus, system, and method for detecting physiological movement from audio and multimodal signals

    WO2018050913A1

  • Method and system for providing behavioural therapy for insomnia

    CN102448368A

  • Sleep monitoring

    CN107920753A

  • System and Method for Diagnosis and Treatment of a Breathing Pattern of a Patient

    US20160151593A1

  • Sleep management and sleep efficiency calculation method using wearable device and mobile application

    WO2017026607A2